 | • レポートコード：QAF27765 • 出版社/出版日：QYResearch / 2021年4月8日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のリポソームドラッグデリバリー市場について種類別（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他）、用途別（真菌感染症治療、がん・腫瘍治療、その他）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・リポソームドラッグデリバリー市場の概要 ・世界の主要地域別リポソームドラッグデリバリー市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のリポソームドラッグデリバリー市場規模2016-2021：種類別（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他） ・世界のリポソームドラッグデリバリー市場予測2012-2027：種類別（リポソームドキソルビシン、リポソームアンホテラシンB、リポソームパクリタキセル、その他） ・世界のリポソームドラッグデリバリー市場規模2016-2021：用途別（真菌感染症治療、がん・腫瘍治療、その他） ・世界のリポソームドラッグデリバリー市場予測2012-2027：用途別（真菌感染症治療、がん・腫瘍治療、その他） ・リポソームドラッグデリバリーのアメリカ市場規模と予測2016-2021 ・リポソームドラッグデリバリーのヨーロッパ市場規模と予測2016-2021 ・リポソームドラッグデリバリーの中国市場規模と予測2016-2021 ・リポソームドラッグデリバリーの日本市場規模と予測2016-2021 ・リポソームドラッグデリバリーの東南アジア市場規模と予測2016-2021 ・リポソームドラッグデリバリーのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Gilead Sciences、Pacira、Sun Pharmaceutical、Johnson & Johnson、Luye Pharma、Sigma-Tau、Ipsen (Onivyde)、CSPC、Teva Pharmaceutical、Novartis、Fudan-Zhangjiang） ・リポソームドラッグデリバリーの製造コスト分析 ・販売チャネル、流通業者、顧客 ・リポソームドラッグデリバリーの市場動向・機会・課題 ・調査の結論 |
Liposomes have been used to improve the therapeutic index of new or established drugs by modifying drug absorption, reducing metabolism, prolonging biological half-life or reducing toxicity. Drug distribution is then controlled primarily by properties of the carrier and no longer by physico-chemical characteristics of the drug substance only.
In the last several years, the development of Liposomes Drug Delivery market is fast with an average growth rate of 13.52%. In 2017, the global revenue of Liposomes Drug Delivery market is nearly 2.30 billion USD.
Market Analysis and Insights: Global Liposome Drug Delivery Market
The global Liposome Drug Delivery market was valued at US$ 4302 in 2020 and will reach US$ 8861.8 million by the end of 2027, growing at a CAGR of 12.8% during 2022-2027.
Global Liposome Drug Delivery Scope and Market Size
The global Liposome Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liposome Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Others
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Others
The Liposome Drug Delivery market is analysed and market size information is provided by regions (countries). Segment by Application, the Liposome Drug Delivery market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Gilead Sciences
Pacira
Sun Pharmaceutical
Johnson & Johnson
Luye Pharma
Sigma-Tau
Ipsen (Onivyde)
CSPC
Teva Pharmaceutical
Novartis
Fudan-Zhangjiang
1 Liposome Drug Delivery Market Overview
1.1 Liposome Drug Delivery Product Scope
1.2 Liposome Drug Delivery Segment by Type
1.2.1 Global Liposome Drug Delivery Sales by Type (2016 & 2021 & 2027)
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Others
1.3 Liposome Drug Delivery Segment by Application
1.3.1 Global Liposome Drug Delivery Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Others
1.4 Liposome Drug Delivery Market Estimates and Forecasts (2016-2027)
1.4.1 Global Liposome Drug Delivery Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Liposome Drug Delivery Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Liposome Drug Delivery Price Trends (2016-2027)
2 Liposome Drug Delivery Estimates and Forecasts by Region
2.1 Global Liposome Drug Delivery Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Liposome Drug Delivery Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Liposome Drug Delivery Sales Market Share by Region (2016-2021)
2.2.2 Global Liposome Drug Delivery Revenue Market Share by Region (2016-2021)
2.3 Global Liposome Drug Delivery Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Liposome Drug Delivery Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Liposome Drug Delivery Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Liposome Drug Delivery Estimates and Projections (2016-2027)
2.4.2 Europe Liposome Drug Delivery Estimates and Projections (2016-2027)
2.4.3 China Liposome Drug Delivery Estimates and Projections (2016-2027)
2.4.4 Japan Liposome Drug Delivery Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Liposome Drug Delivery Estimates and Projections (2016-2027)
2.4.6 India Liposome Drug Delivery Estimates and Projections (2016-2027)
3 Global Liposome Drug Delivery Competition Landscape by Players
3.1 Global Top Liposome Drug Delivery Players by Sales (2016-2021)
3.2 Global Top Liposome Drug Delivery Players by Revenue (2016-2021)
3.3 Global Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liposome Drug Delivery as of 2020)
3.4 Global Liposome Drug Delivery Average Price by Company (2016-2021)
3.5 Manufacturers Liposome Drug Delivery Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Liposome Drug Delivery Market Size by Type
4.1 Global Liposome Drug Delivery Historic Market Review by Type (2016-2021)
4.1.1 Global Liposome Drug Delivery Sales Market Share by Type (2016-2021)
4.1.2 Global Liposome Drug Delivery Revenue Market Share by Type (2016-2021)
4.1.3 Global Liposome Drug Delivery Price by Type (2016-2021)
4.2 Global Liposome Drug Delivery Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Liposome Drug Delivery Sales Forecast by Type (2022-2027)
4.2.2 Global Liposome Drug Delivery Revenue Forecast by Type (2022-2027)
4.2.3 Global Liposome Drug Delivery Price Forecast by Type (2022-2027)
5 Global Liposome Drug Delivery Market Size by Application
5.1 Global Liposome Drug Delivery Historic Market Review by Application (2016-2021)
5.1.1 Global Liposome Drug Delivery Sales Market Share by Application (2016-2021)
5.1.2 Global Liposome Drug Delivery Revenue Market Share by Application (2016-2021)
5.1.3 Global Liposome Drug Delivery Price by Application (2016-2021)
5.2 Global Liposome Drug Delivery Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Liposome Drug Delivery Sales Forecast by Application (2022-2027)
5.2.2 Global Liposome Drug Delivery Revenue Forecast by Application (2022-2027)
5.2.3 Global Liposome Drug Delivery Price Forecast by Application (2022-2027)
6 North America Liposome Drug Delivery Market Facts & Figures
6.1 North America Liposome Drug Delivery Sales by Company
6.1.1 North America Liposome Drug Delivery Sales by Company (2016-2021)
6.1.2 North America Liposome Drug Delivery Revenue by Company (2016-2021)
6.2 North America Liposome Drug Delivery Sales Breakdown by Type
6.2.1 North America Liposome Drug Delivery Sales Breakdown by Type (2016-2021)
6.2.2 North America Liposome Drug Delivery Sales Breakdown by Type (2022-2027)
6.3 North America Liposome Drug Delivery Sales Breakdown by Application
6.3.1 North America Liposome Drug Delivery Sales Breakdown by Application (2016-2021)
6.3.2 North America Liposome Drug Delivery Sales Breakdown by Application (2022-2027)
7 Europe Liposome Drug Delivery Market Facts & Figures
7.1 Europe Liposome Drug Delivery Sales by Company
7.1.1 Europe Liposome Drug Delivery Sales by Company (2016-2021)
7.1.2 Europe Liposome Drug Delivery Revenue by Company (2016-2021)
7.2 Europe Liposome Drug Delivery Sales Breakdown by Type
7.2.1 Europe Liposome Drug Delivery Sales Breakdown by Type (2016-2021)
7.2.2 Europe Liposome Drug Delivery Sales Breakdown by Type (2022-2027)
7.3 Europe Liposome Drug Delivery Sales Breakdown by Application
7.3.1 Europe 140 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 140 Sales Breakdown by Application (2022-2027)
8 China Liposome Drug Delivery Market Facts & Figures
8.1 China Liposome Drug Delivery Sales by Company
8.1.1 China Liposome Drug Delivery Sales by Company (2016-2021)
8.1.2 China Liposome Drug Delivery Revenue by Company (2016-2021)
8.2 China Liposome Drug Delivery Sales Breakdown by Type
8.2.1 China Liposome Drug Delivery Sales Breakdown by Type (2016-2021)
8.2.2 China Liposome Drug Delivery Sales Breakdown by Type (2022-2027)
8.3 China Liposome Drug Delivery Sales Breakdown by Application
8.3.1 China 316 Sales Breakdown by Application (2016-2021)
8.3.2 China 316 Sales Breakdown by Application (2022-2027)
9 Japan Liposome Drug Delivery Market Facts & Figures
9.1 Japan Liposome Drug Delivery Sales by Company
9.1.1 Japan Liposome Drug Delivery Sales by Company (2016-2021)
9.1.2 Japan Liposome Drug Delivery Revenue by Company (2016-2021)
9.2 Japan Liposome Drug Delivery Sales Breakdown by Type
9.2.1 Japan Liposome Drug Delivery Sales Breakdown by Type (2016-2021)
9.2.2 Japan Liposome Drug Delivery Sales Breakdown by Type (2022-2027)
9.3 Japan Liposome Drug Delivery Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Liposome Drug Delivery Market Facts & Figures
10.1 Southeast Asia Liposome Drug Delivery Sales by Company
10.1.1 Southeast Asia Liposome Drug Delivery Sales by Company (2016-2021)
10.1.2 Southeast Asia Liposome Drug Delivery Revenue by Company (2016-2021)
10.2 Southeast Asia Liposome Drug Delivery Sales Breakdown by Type
10.2.1 Southeast Asia Liposome Drug Delivery Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Liposome Drug Delivery Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Liposome Drug Delivery Sales Breakdown by Application
10.3.1 Southeast Asia K Vial Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Vial Sales Breakdown by Application (2022-2027)
11 India Liposome Drug Delivery Market Facts & Figures
11.1 India Liposome Drug Delivery Sales by Company
11.1.1 India Liposome Drug Delivery Sales by Company (2016-2021)
11.1.2 India Liposome Drug Delivery Revenue by Company (2016-2021)
11.2 India Liposome Drug Delivery Sales Breakdown by Type
11.2.1 India Liposome Drug Delivery Sales Breakdown by Type (2016-2021)
11.2.2 India Liposome Drug Delivery Sales Breakdown by Type (2022-2027)
11.3 India Liposome Drug Delivery Sales Breakdown by Application
11.3.1 India Liposome Drug Delivery Sales Breakdown by Application (2016-2021)
11.3.2 India Liposome Drug Delivery Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Liposome Drug Delivery Business
12.1 Gilead Sciences
12.1.1 Gilead Sciences Corporation Information
12.1.2 Gilead Sciences Business Overview
12.1.3 Gilead Sciences Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Gilead Sciences Liposome Drug Delivery Products Offered
12.1.5 Gilead Sciences Recent Development
12.2 Pacira
12.2.1 Pacira Corporation Information
12.2.2 Pacira Business Overview
12.2.3 Pacira Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pacira Liposome Drug Delivery Products Offered
12.2.5 Pacira Recent Development
12.3 Sun Pharmaceutical
12.3.1 Sun Pharmaceutical Corporation Information
12.3.2 Sun Pharmaceutical Business Overview
12.3.3 Sun Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sun Pharmaceutical Liposome Drug Delivery Products Offered
12.3.5 Sun Pharmaceutical Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Corporation Information
12.4.2 Johnson & Johnson Business Overview
12.4.3 Johnson & Johnson Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Johnson & Johnson Liposome Drug Delivery Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Luye Pharma
12.5.1 Luye Pharma Corporation Information
12.5.2 Luye Pharma Business Overview
12.5.3 Luye Pharma Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Luye Pharma Liposome Drug Delivery Products Offered
12.5.5 Luye Pharma Recent Development
12.6 Sigma-Tau
12.6.1 Sigma-Tau Corporation Information
12.6.2 Sigma-Tau Business Overview
12.6.3 Sigma-Tau Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Sigma-Tau Liposome Drug Delivery Products Offered
12.6.5 Sigma-Tau Recent Development
12.7 Ipsen (Onivyde)
12.7.1 Ipsen (Onivyde) Corporation Information
12.7.2 Ipsen (Onivyde) Business Overview
12.7.3 Ipsen (Onivyde) Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Ipsen (Onivyde) Liposome Drug Delivery Products Offered
12.7.5 Ipsen (Onivyde) Recent Development
12.8 CSPC
12.8.1 CSPC Corporation Information
12.8.2 CSPC Business Overview
12.8.3 CSPC Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.8.4 CSPC Liposome Drug Delivery Products Offered
12.8.5 CSPC Recent Development
12.9 Teva Pharmaceutical
12.9.1 Teva Pharmaceutical Corporation Information
12.9.2 Teva Pharmaceutical Business Overview
12.9.3 Teva Pharmaceutical Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Teva Pharmaceutical Liposome Drug Delivery Products Offered
12.9.5 Teva Pharmaceutical Recent Development
12.10 Novartis
12.10.1 Novartis Corporation Information
12.10.2 Novartis Business Overview
12.10.3 Novartis Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Novartis Liposome Drug Delivery Products Offered
12.10.5 Novartis Recent Development
12.11 Fudan-Zhangjiang
12.11.1 Fudan-Zhangjiang Corporation Information
12.11.2 Fudan-Zhangjiang Business Overview
12.11.3 Fudan-Zhangjiang Liposome Drug Delivery Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Fudan-Zhangjiang Liposome Drug Delivery Products Offered
12.11.5 Fudan-Zhangjiang Recent Development
13 Liposome Drug Delivery Manufacturing Cost Analysis
13.1 Liposome Drug Delivery Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Liposome Drug Delivery
13.4 Liposome Drug Delivery Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Liposome Drug Delivery Distributors List
14.3 Liposome Drug Delivery Customers
15 Market Dynamics
15.1 Liposome Drug Delivery Market Trends
15.2 Liposome Drug Delivery Drivers
15.3 Liposome Drug Delivery Market Challenges
15.4 Liposome Drug Delivery Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Liposome Drug Delivery Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Liposome Drug Delivery Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Liposome Drug Delivery Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Liposome Drug Delivery Sales (K Vial) by Region (2016-2021)
Table 5. Global Liposome Drug Delivery Sales Market Share by Region (2016-2021)
Table 6. Global Liposome Drug Delivery Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Liposome Drug Delivery Revenue Share by Region (2016-2021)
Table 8. Global Liposome Drug Delivery Sales (K Vial) Forecast by Region (2022-2027)
Table 9. Global Liposome Drug Delivery Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Liposome Drug Delivery Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Liposome Drug Delivery Revenue Share Forecast by Region (2022-2027)
Table 12. Global Liposome Drug Delivery Sales (K Vial) of Key Companies (2016-2021)
Table 13. Global Liposome Drug Delivery Sales Share by Company (2016-2021)
Table 14. Global Liposome Drug Delivery Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Liposome Drug Delivery Revenue Share by Company (2016-2021)
Table 16. Global Liposome Drug Delivery by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposome Drug Delivery as of 2020)
Table 17. Global Liposome Drug Delivery Average Price (USD/Vial) of Key Company (2016-2021)
Table 18. Manufacturers Liposome Drug Delivery Manufacturing Sites and Area Served
Table 19. Manufacturers Liposome Drug Delivery Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Liposome Drug Delivery Sales (K Vial) by Type (2016-2021)
Table 22. Global Liposome Drug Delivery Sales Share by Type (2016-2021)
Table 23. Global Liposome Drug Delivery Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Liposome Drug Delivery Price (USD/Vial) by Type (2016-2021)
Table 25. Global Liposome Drug Delivery Sales Share by Type (2022-2027)
Table 26. Global Liposome Drug Delivery Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Liposome Drug Delivery Revenue Share by Type (2022-2027)
Table 28. Global Liposome Drug Delivery Price (USD/Vial) by Type (2022-2027)
Table 29. Global Liposome Drug Delivery Sales (K Vial) by Application (2016-2021)
Table 30. Global Liposome Drug Delivery Sales Share by Application (2016-2021)
Table 31. Global Liposome Drug Delivery Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Liposome Drug Delivery Price (USD/Vial) by Application (2016-2021)
Table 33. Global Liposome Drug Delivery Sales (K Vial) by Application (2022-2027)
Table 34. Global Liposome Drug Delivery Sales Share by Application (2022-2027)
Table 35. Global Liposome Drug Delivery Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Liposome Drug Delivery Revenue Share by Application (2022-2027)
Table 37. Global Liposome Drug Delivery Price (USD/Vial) by Application (2022-2027)
Table 38. North America Liposome Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 39. North America Liposome Drug Delivery Sales Market Share by Company (2016-2021)
Table 40. North America Liposome Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Liposome Drug Delivery Revenue Market Share by Company (2016-2021)
Table 42. North America Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 43. North America Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Table 44. North America Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 45. North America Liposome Drug Delivery Sales Market Share by Type (2022-2027)
Table 46. North America Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 47. North America Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Table 48. North America Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 49. North America Liposome Drug Delivery Sales Market Share by Application (2022-2027)
Table 50. Europe Liposome Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 51. Europe Liposome Drug Delivery Sales Market Share by Company (2016-2021)
Table 52. Europe Liposome Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Liposome Drug Delivery Revenue Market Share by Company (2016-2021)
Table 54. Europe Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 55. Europe Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Table 56. Europe Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 57. Europe Liposome Drug Delivery Sales Market Share by Type (2022-2027)
Table 58. Europe Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 59. Europe Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Table 60. Europe Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 61. Europe Liposome Drug Delivery Sales Market Share by Application (2022-2027)
Table 62. China Liposome Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 63. China Liposome Drug Delivery Sales Market Share by Company (2016-2021)
Table 64. China Liposome Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Liposome Drug Delivery Revenue Market Share by Company (2016-2021)
Table 66. China Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 67. China Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Table 68. China Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 69. China Liposome Drug Delivery Sales Market Share by Type (2022-2027)
Table 70. China Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 71. China Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Table 72. China Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 73. China Liposome Drug Delivery Sales Market Share by Application (2022-2027)
Table 74. Japan Liposome Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 75. Japan Liposome Drug Delivery Sales Market Share by Company (2016-2021)
Table 76. Japan Liposome Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Liposome Drug Delivery Revenue Market Share by Company (2016-2021)
Table 78. Japan Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 79. Japan Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Table 80. Japan Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 81. Japan Liposome Drug Delivery Sales Market Share by Type (2022-2027)
Table 82. Japan Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 83. Japan Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Table 84. Japan Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 85. Japan Liposome Drug Delivery Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Liposome Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 87. Southeast Asia Liposome Drug Delivery Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Liposome Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Liposome Drug Delivery Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 91. Southeast Asia Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 93. Southeast Asia Liposome Drug Delivery Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 95. Southeast Asia Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 97. Southeast Asia Liposome Drug Delivery Sales Market Share by Application (2022-2027)
Table 98. India Liposome Drug Delivery Sales (K Vial) by Company (2016-2021)
Table 99. India Liposome Drug Delivery Sales Market Share by Company (2016-2021)
Table 100. India Liposome Drug Delivery Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Liposome Drug Delivery Revenue Market Share by Company (2016-2021)
Table 102. India Liposome Drug Delivery Sales by Type (2016-2021) & (K Vial)
Table 103. India Liposome Drug Delivery Sales Market Share by Type (2016-2021)
Table 104. India Liposome Drug Delivery Sales by Type (2022-2027) & (K Vial)
Table 105. India Liposome Drug Delivery Sales Market Share by Type (2022-2027)
Table 106. India Liposome Drug Delivery Sales by Application (2016-2021) & (K Vial)
Table 107. India Liposome Drug Delivery Sales Market Share by Application (2016-2021)
Table 108. India Liposome Drug Delivery Sales by Application (2022-2027) & (K Vial)
Table 109. India Liposome Drug Delivery Sales Market Share by Application (2022-2027)
Table 110. Gilead Sciences Corporation Information
Table 111. Gilead Sciences Description and Business Overview
Table 112. Gilead Sciences Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 113. Gilead Sciences Liposome Drug Delivery Product
Table 114. Gilead Sciences Recent Development
Table 115. Pacira Corporation Information
Table 116. Pacira Description and Business Overview
Table 117. Pacira Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 118. Pacira Liposome Drug Delivery Product
Table 119. Pacira Recent Development
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 123. Sun Pharmaceutical Liposome Drug Delivery Product
Table 124. Sun Pharmaceutical Recent Development
Table 125. Johnson & Johnson Corporation Information
Table 126. Johnson & Johnson Description and Business Overview
Table 127. Johnson & Johnson Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 128. Johnson & Johnson Liposome Drug Delivery Product
Table 129. Johnson & Johnson Recent Development
Table 130. Luye Pharma Corporation Information
Table 131. Luye Pharma Description and Business Overview
Table 132. Luye Pharma Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 133. Luye Pharma Liposome Drug Delivery Product
Table 134. Luye Pharma Recent Development
Table 135. Sigma-Tau Corporation Information
Table 136. Sigma-Tau Description and Business Overview
Table 137. Sigma-Tau Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 138. Sigma-Tau Liposome Drug Delivery Product
Table 139. Sigma-Tau Recent Development
Table 140. Ipsen (Onivyde) Corporation Information
Table 141. Ipsen (Onivyde) Description and Business Overview
Table 142. Ipsen (Onivyde) Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 143. Ipsen (Onivyde) Liposome Drug Delivery Product
Table 144. Ipsen (Onivyde) Recent Development
Table 145. CSPC Corporation Information
Table 146. CSPC Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 147. CSPC Description and Business Overview
Table 148. CSPC Liposome Drug Delivery Product
Table 149. CSPC Recent Development
Table 150. Teva Pharmaceutical Corporation Information
Table 151. Teva Pharmaceutical Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 152. Teva Pharmaceutical Description and Business Overview
Table 153. Teva Pharmaceutical Liposome Drug Delivery Product
Table 154. Teva Pharmaceutical Recent Development
Table 155. Novartis Corporation Information
Table 156. Novartis Description and Business Overview
Table 157. Novartis Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 158. Novartis Liposome Drug Delivery Product
Table 159. Novartis Recent Development
Table 160. Fudan-Zhangjiang Corporation Information
Table 161. Fudan-Zhangjiang Description and Business Overview
Table 162. Fudan-Zhangjiang Liposome Drug Delivery Sales (K Vial), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2016-2021)
Table 163. Fudan-Zhangjiang Liposome Drug Delivery Product
Table 164. Fudan-Zhangjiang Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Liposome Drug Delivery Distributors List
Table 168. Liposome Drug Delivery Customers List
Table 169. Liposome Drug Delivery Market Trends
Table 170. Liposome Drug Delivery Market Drivers
Table 171. Liposome Drug Delivery Market Challenges
Table 172. Liposome Drug Delivery Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposome Drug Delivery Product Picture
Figure 2. Global Liposome Drug Delivery Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liposome Drug Delivery Sales Market Share by Application in 2021 & 2027
Figure 6. Fungal Infection Therapy Examples
Figure 7. Cancer & Tumor Therapy Examples
Figure 8. Others Examples
Figure 9. Global Liposome Drug Delivery Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Liposome Drug Delivery Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Liposome Drug Delivery Sales (K Vial) Growth Rate (2016-2027)
Figure 12. Global Liposome Drug Delivery Price Trends Growth Rate (2016-2027) (USD/Vial)
Figure 13. Global Liposome Drug Delivery Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Liposome Drug Delivery Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Liposome Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Liposome Drug Delivery Sales (K Vial) Growth Rate (2016-2027)
Figure 17. Europe Liposome Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Liposome Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Liposome Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Liposome Drug Delivery Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Liposome Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Liposome Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Liposome Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Liposome Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Liposome Drug Delivery Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Liposome Drug Delivery Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Liposome Drug Delivery Players Market Share by Revenue in Liposome Drug Delivery: 2016 & 2020
Figure 28. Liposome Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Liposome Drug Delivery Revenue Share by Type (2016-2021)
Figure 30. Global Liposome Drug Delivery Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Liposome Drug Delivery Revenue Share by Application (2016-2021)
Figure 32. Global Liposome Drug Delivery Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Liposome Drug Delivery Sales Market Share by Type in 2020
Figure 34. North America Liposome Drug Delivery Sales Market Share by Application in 2020
Figure 35. Europe Liposome Drug Delivery Sales Market Share by Type in 2020
Figure 36. Europe Liposome Drug Delivery Sales Market Share by Application in 2020
Figure 37. China Liposome Drug Delivery Sales Market Share by Type in 2020
Figure 38. China Liposome Drug Delivery Sales Market Share by Application in 2020
Figure 39. Japan Liposome Drug Delivery Sales Market Share by Type in 2020
Figure 40. Japan Liposome Drug Delivery Sales Market Share by Application in 2020
Figure 41. Southeast Asia Liposome Drug Delivery Sales Market Share by Type in 2020
Figure 42. Southeast Asia Liposome Drug Delivery Sales Market Share by Application in 2020
Figure 43. India Liposome Drug Delivery Sales Market Share by Type in 2020
Figure 44. India Liposome Drug Delivery Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Liposome Drug Delivery
Figure 47. Manufacturing Process Analysis of Liposome Drug Delivery
Figure 48. Liposome Drug Delivery Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
眼用薬物デリバリーのグローバル市場調査 2019年 The global Ocular Drug Delivery market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ocular Drug Delivery volume and value at global level, regional level and company level. From a global perspective, th…- 鼻腔内用ドラッグデリバリーデバイスのグローバル市場2021 Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through n…
- 世界の経粘膜薬物送達システム市場規模・現状・予測（2021年-2027年） The transmucosal route includes oral, nasal, vaginal, and urethral and presents a challenge in the field of novel drug delivery technology. The transmucosal membranes are relatively permeable, have a rich blood flow and hence allow the rapid uptake of a drug into systemic circulation to avoid first …
- 世界の小分子ドラッグデリバリー市場規模・現状・予測（2021年-2027年） The small molecules drugs are able to enter cells easily because of its low molecular weight. These molecules are better than monoclonal antibodies and other large molecule drugs due to their size, easy convertibility to oral form and cost affectivity. The discovery of novel small molecule entities …
- 世界のドラッグデリバリーアクロス血液脳関門市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Drug Delivery Across Blood Brain Barrier Market The global Drug Delivery Across Blood Brain Barrier market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analys…